Answers are grounded in this paper and cite their sources.
, and restore carbapenem potency against clinical isolates expressing B1 MBLs. Based on their inhibitory profile and lack of eukaryotic cell toxicity, MMTZs represent a promising scaffold for MBL inhibitor development. These results also suggest sulphur-π interactions can be exploited for general ligand design in medicinal chemistry.
No takes yet. Share an insight, caveat, or question.
Rossi et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: